{
  "meta": {
    "disclaimer": "Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service.",
    "terms": "https://open.fda.gov/terms/",
    "license": "https://open.fda.gov/license/",
    "last_updated": "2026-09-29",
    "results": {
      "skip": 0,
      "limit": 1,
      "total": 1
    }
  },
  "results": [
    {
      "product_ndc": "0615-8263",
      "generic_name": "Amantadine Hydrochloride",
      "labeler_name": "NCS HealthCare of KY, LLC dba Vangard Labs",
      "brand_name": "Amantadine Hydrochloride",
      "active_ingredients": [
        {
          "name": "AMANTADINE HYDROCHLORIDE",
          "strength": "100 mg/1"
        }
      ],
      "finished": true,
      "packaging": [
        {
          "package_ndc": "0615-8263-39",
          "description": "30 CAPSULE in 1 BLISTER PACK (0615-8263-39)",
          "marketing_start_date": "20190110",
          "sample": false
        }
      ],
      "listing_expiration_date": "20261231",
      "openfda": {
        "manufacturer_name": [
          "NCS HealthCare of KY, LLC dba Vangard Labs"
        ],
        "rxcui": [
          "849389"
        ],
        "spl_set_id": [
          "b54064bc-b3e1-4d83-be40-fcaddd2e99d0"
        ],
        "unii": [
          "M6Q1EO9TD0"
        ]
      },
      "marketing_category": "ANDA",
      "dosage_form": "CAPSULE",
      "spl_id": "056d9ef2-8e38-40eb-8d3a-0d753e018030",
      "product_type": "HUMAN PRESCRIPTION DRUG",
      "route": [
        "ORAL"
      ],
      "marketing_start_date": "20170101",
      "product_id": "0615-8263_056d9ef2-8e38-40eb-8d3a-0d753e018030",
      "application_number": "ANDA209171",
      "brand_name_base": "Amantadine Hydrochloride",
      "pharm_class": [
        "Influenza A M2 Protein Inhibitor [EPC]",
        "M2 Protein Inhibitors [MoA]"
      ]
    }
  ]
}